{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:05:00Z","timestamp":1784891100464,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["2052-00054B"],"award-info":[{"award-number":["2052-00054B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110862","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:22:36Z","timestamp":1769790156000},"page":"110862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacological modulation of wakefulness and extracellular hypothalamic histamine release in adult male mice using TAK-925, modafinil, pitolisant, MK-8133 and Lu AF11167"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4522-8055","authenticated-orcid":false,"given":"Camille G.","family":"Hviid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte R.","family":"Kornum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-0394","authenticated-orcid":false,"given":"Kjartan F.","family":"Herrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6669","key":"10.1016\/j.neuropharm.2026.110862_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.adh8285","article-title":"Sleep and the hypothalamus","volume":"382","author":"Adamantidis","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110862_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fnins.2019.00207","article-title":"Validation of 'Somnivore', a machine learning algorithm for automated scoring and analysis of polysomnography data","volume":"13","author":"Allocca","year":"2019","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110862_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.118.248120","article-title":"Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor","volume":"366","author":"Baladi","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.110862_bib4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa2405847","article-title":"Oveporexton, an oral orexin receptor 2-Selective agonist, in narcolepsy type 1","volume":"392","author":"Dauvilliers","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.neuropharm.2026.110862_bib6","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200111160-00032","article-title":"Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats","volume":"12","author":"de Saint Hilaire","year":"2001","journal-title":"Neuroreport"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110862_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neuron.2023.02.024","article-title":"Genetically encoded sensors for measuring histamine release both in vitro and in vivo","volume":"111","author":"Dong","year":"2023","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110862_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/npp.2017.294","article-title":"Neuronal mechanisms for Sleep\/Wake regulation and modulatory drive","volume":"43","author":"Eban-Rothschild","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110862_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fphar.2013.00163","article-title":"Orexin receptor antagonists as therapeutic agents for insomnia","volume":"4","author":"Equihua","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.neuropharm.2026.110862_bib10","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","article-title":"Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus","volume":"21","author":"Eriksson","year":"2001","journal-title":"J. Neurosci."},{"issue":"35","key":"10.1016\/j.neuropharm.2026.110862_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207531119","article-title":"Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients","volume":"119","author":"Evans","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110862_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13878","article-title":"Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals","volume":"32","author":"Evans","year":"2023","journal-title":"J. Sleep Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110862_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070761","article-title":"Histamine H(3) receptor isoforms: insights from alternative splicing to functional complexity","volume":"14","author":"Gao","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110862_bib14","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110862_bib15","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1460-9568.2009.06765.x","article-title":"Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat","volume":"29","author":"Giannoni","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110862_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.baga.2012.12.001","article-title":"Cellular distribution of the histamine H3 receptor in the basal ganglia: functional modulation of dopamine and glutamate neurotransmission","volume":"3","author":"Gonz\u00e1lez-Sep\u00falveda","year":"2013","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.neuropharm.2026.110862_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2147\/NSS.S264140","article-title":"Pitolisant to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy: rationale and clinical utility","volume":"12","author":"Guevarra","year":"2020","journal-title":"Nat. Sci. Sleep"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110862_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110862_bib20","article-title":"Pitolisant and other Histamine-3 receptor Antagonists-An update on therapeutic potentials and clinical prospects","volume":"7","author":"Harwell","year":"2020","journal-title":"Medicines (Basel)"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110862_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw030","article-title":"Phosphodiesterase inhibition and regulation of dopaminergic frontal and striatal functioning: clinical implications","volume":"19","author":"Heckman","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110862_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.apha.2023.10.006","article-title":"Modafinil, an atypical CNS stimulant?","volume":"99","author":"Hersey","year":"2024","journal-title":"Adv. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110862_bib23","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1073\/pnas.0600451103","article-title":"Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice","volume":"103","author":"Huang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110862_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrn1034","article-title":"The role of histamine and the tuberomamillary nucleus in the nervous system","volume":"4","author":"Haas","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2026.110862_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2007.09.009","article-title":"Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats","volume":"578","author":"Ishizuka","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110862_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2010.08.005","article-title":"Modanifil activates the histaminergic system through the orexinergic neurons","volume":"483","author":"Ishizuka","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41398-024-03087-4","article-title":"Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review","volume":"14","author":"Kishi","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110862_bib29","article-title":"Pde10a gates light responses in the SCN to regulate circadian photoentrainment","author":"Komal","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110862_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.855","article-title":"Pitolisant, a wake-promoting agent devoid of psychostimulant properties: preclinical comparison with amphetamine, modafinil, and solriamfetol","volume":"9","author":"Krief","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110862_bib31","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.bmcl.2015.04.066","article-title":"Identification of MK-8133: an orexin-2 selective receptor antagonist with favorable development properties","volume":"25","author":"Kuduk","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/9780470942390.mo110126","article-title":"Sleep and EEG phenotyping in mice","volume":"2","author":"Mang","year":"2012","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.110862_bib33","article-title":"PDE10A inhibitors-clinical failure or window into antipsychotic drug action?","volume":"14","author":"Menniti","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110862_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.05.009","article-title":"A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia","volume":"61","author":"Meyer-Lindenberg","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70594-1","article-title":"TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models","volume":"14","author":"Mitsukawa","year":"2024","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.110862_bib36","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1111\/bph.15664","article-title":"Pivotal role of phosphodiesterase 10A in the integration of dopamine signals in mice striatal D(1) and D(2) medium-sized spiny neurones","volume":"178","author":"Mota","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110862_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0306-4522(89)90007-9","article-title":"Histamine-immunoreactive nerve fibers in the rat brain","volume":"28","author":"Panula","year":"1989","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110862_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bcp.2007.01.002","article-title":"The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders","volume":"73","author":"Parmentier","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110862_bib39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0166-2236(00)02002-6","article-title":"The sleep switch: hypothalamic control of sleep and wakefulness","volume":"24","author":"Saper","year":"2001","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110862_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuron.2017.01.014","article-title":"Neural circuitry of wakefulness and sleep","volume":"93","author":"Scammell","year":"2017","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy183","article-title":"Histamine: neural circuits and new medications","volume":"42","author":"Scammell","year":"2019","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110862_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110862_bib43","first-page":"615","article-title":"The neurobiology of sleep and wakefulness","volume":"38","author":"Schwartz","year":"2015","journal-title":"Psychiatr. Clin."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110862_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2015.99","article-title":"Interactions of the histamine and hypocretin systems in CNS disorders","volume":"11","author":"Shan","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110862_bib45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41593-022-01236-w","article-title":"Neuro-orchestration of sleep and wakefulness","volume":"26","author":"Sulaman","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110862_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13839","article-title":"Evaluation of the efficacy of the hypocretin\/orexin receptor agonists TAK-925 and ARN-776 in narcoleptic orexin\/tTA; TetO-DTA mice","volume":"32","author":"Sun","year":"2023","journal-title":"J. Sleep Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110862_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.55782\/ane-2010-1769","article-title":"Effects of phosphodiesterase 10 inhibition on striatal cyclic AMP and peripheral physiology in rats","volume":"70","author":"Torremans","year":"2010","journal-title":"Acta Neurobiol. Exp."},{"issue":"21\u201322","key":"10.1016\/j.neuropharm.2026.110862_bib49","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1007\/s00213-016-4412-9","article-title":"A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor","volume":"233","author":"Tsai","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"13","key":"10.1016\/j.neuropharm.2026.110862_bib50","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00213-016-4290-1","article-title":"Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity","volume":"233","author":"Vardigan","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110862_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3940(83)90308-7","article-title":"Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis","volume":"39","author":"Watanabe","year":"1983","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110862_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz031","article-title":"Genetic lesioning of histamine neurons increases sleep-wake fragmentation and reveals their contribution to modafinil-induced wakefulness","volume":"42","author":"Yu","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2026.110862_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172794","article-title":"TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice","volume":"187","author":"Yukitake","year":"2019","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:59:16Z","timestamp":1779004756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"alternative-id":["S0028390826000353"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110862","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation of wakefulness and extracellular hypothalamic histamine release in adult male mice using TAK-925, modafinil, pitolisant, MK-8133 and Lu AF11167","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110862"}}